Our analysis using the HPA datasets showed that, while SPR expression was relatively consistent between normal brain and tumor tissues, the other three members of the pathway were expressed at higher levels in glioma tumors than in normal cells (Fig. 4a-b). The gene discussed is SPR; the disease is central nervous system cancer.